Research programme: cancer vaccines - Flow Pharma
Alternative Names: Cervical cancer vaccine - Flow Pharma; FlowVax BreastCA - Flow Pharma; FlowVax HPV - Flow Pharma; FlowVax peptide vaccine - Flow Pharma; FlowVax™; Head and neck cancer vaccine - Flow Pharma; Throat cancer vaccine - Flow PharmaLatest Information Update: 28 Mar 2025
At a glance
- Originator Flow Pharma
- Class Cancer vaccines; Peptide vaccines
- Mechanism of Action Immunologic cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer; Cervical cancer; Head and neck cancer
Most Recent Events
- 28 Mar 2025 No recent reports of development identified for preclinical development in Head-and-neck-cancer in USA (Intralymphatic, Injection)
- 28 May 2024 No recent reports of development identified for preclinical development in Breast-cancer in USA (Intralymphatic, Injection)
- 28 Oct 2022 No recent reports of development identified for preclinical development in Cervical-cancer in USA (Intralymphatic, Injection)